USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: CELSENSE, INC.
Address: 603 STANWIX STREET
SUITE 348
PITTSBURGH, PA 15222-
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $273,009.00 1
STTR Phase I $511,442.00 2

Award List:

Analysis of Cell Sense Labeled Human Cells

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $273,009.00
Abstract:
DESCRIPTION (provided by applicant): Cellular therapeutics represent great potential for curing and alleviating symptoms associated with debilitating human diseases, such as cancer, cardiovascular disease, and neurological disorders. Currently, no versatil e methodology for tracking cellular… More

Dual Mode Nanoemulsions for 19F MRI and Fluorescence Detection

Award Year / Program / Phase: 2009 / STTR / Phase I
Agency: HHS
Research Institution: DUQUESNE UNIVERSITY
Principal Investigator: Jelenam M. Janjic
Award Amount: $132,282.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Recently, scientists at Carnegie Mellon University (CMU) have invented a compelling technology that makes transplanted cells visible with magnetic resonance imaging (MRI). Cells of interest are labeled ex vivo with a n ovel perfluoropolyether (PFPE) nanoemulsion… More

Platform for myocardial infarct MRI and delivery of therapeutics

Award Year / Program / Phase: 2012 / STTR / Phase I
Agency: HHS
Research Institution: CELSENSE, INC.
Principal Investigator: Eric T. Ahrens – 412-268-5105
Award Amount: $379,160.00
RI Contact:
Abstract:
Myocardial infarction (MI) afflicts more than one million persons per year in the United States alone. MI results in permanent left ventricle (LV) scarring that causes diminished pump efficiency and, commonly, heart failure. Towards reduction or elimination of scarring, there is increasing interest… More